PIK3R1
From Wikipedia, the free encyclopedia
(Redirected from P85a)
Template:Short description Template:Cs1 config An Error has occurred retrieving Wikidata item for infobox Phosphatidylinositol 3-kinase regulatory subunit alpha is an enzyme that in humans is encoded by the PIK3R1 gene.[1]
Function
Phosphatidylinositol 3-kinase phosphorylates the inositol ring of phosphatidylinositol at the 3-prime position. The enzyme comprises a 110 kD catalytic subunit and a regulatory subunit of either 85, 55, or 50 kD. The Pik3r1 gene locus encodes the 85 kD regulatory subunit, as well as 55 and 50 kD regulatory subunits. It used to be thought that alternative splicing of this gene resulted in three transcript variants encoding different isoforms.[2] In fact, it has since been shown that the 55 and 50kD subunits have their own promotors within the gene locus Pik3r1.[3]
Phosphatidylinositol 3-kinase plays an important role in the metabolic actions of insulin, and a mutation in this gene has been associated with insulin resistance.[4] Suppression specifically of the 85kD subunit in early murine embryoid body development results in a transient cell-cell adhesion deficiency, mediated by transient downregulation of the adhesion molecule integrin-beta1 (ITGB1).[3]
Clinical significance
Mutations in PIK3R1 are implicated in cases of breast cancer.[5]
Mutations in PIK3R1 are associated to SHORT syndrome.[6]
Interactions
PIK3R1 has been shown to interact with:
Page Template:Div col/styles.css has no content.
- ADAM12,[7]
- BCAR1,[8]
- CBLB,[9][10]
- CD117,[11][12][13]
- CD28,[14]
- CD7,[15][16]
- CENTG1,[17]
- CBL,[18][19][20]
- EPHA2,[21]
- EPOR,[22][23]
- ERBB3,[24][25]
- EZR,[26]
- FCGR2A,[27][28]
- GAB1,[29][30][31]
- GAB2,[32][33]
- Grb2,[34][35]
- HRAS,[36][37]
- IRS1[38][39][40][41]
- IRS2,[38][42][43][44]
- IL1R1,[45]
- JAK2,[46]
- KHDRBS1,[47][48]
- LTK,[49][50]
- LAT,[51]
- LCP2,[52]
- PIK3CD,[53]
- PTK2,[54]
- SHB,[55]
- TUBA1B,[56]
- TYRO3,[57]
- VAV1,[22][29] and
- WAS.[58]
References
Page Template:Reflist/styles.css has no content.
- ^ Page Module:Citation/CS1/styles.css has no content.Volinia S, Patracchini P, Otsu M, Hiles I, Gout I, Calzolari E, Bernardi F, Rooke L, Waterfield MD (May 1992). "Chromosomal localization of human p85 alpha, a subunit of phosphatidylinositol 3-kinase, and its homologue p85 beta". Oncogene. 7 (4): 789–93. PMID 1314371.
- ^ Page Module:Citation/CS1/styles.css has no content."Entrez Gene: PIK3R1 phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha)".
- ^ a b Page Module:Citation/CS1/styles.css has no content.Gurney SM, Forster P, Just U, Schwanbeck R (2011). "Suppression of the PI3K Subunit p85alpha Delays Embryoid Body Development and Inhibits Cell Adhesion". J. Cell. Biochem. 112 (12): 3573–81. doi:10.1002/jcb.23285. PMID 21780162. S2CID 206020214.
- ^ Page Module:Citation/CS1/styles.css has no content."Entrez Gene: PIK3R1 phosphoinositide-3-kinase, regulatory subunit 1 (p85 alpha)".
- ^ Page Module:Citation/CS1/styles.css has no content.The Cancer Genome Atlas Network (October 2012). "Comprehensive molecular portraits of human breast tumours". Nature. 490 (7418): 61–70. Bibcode:2012Natur.490...61T. doi:10.1038/nature11412. PMC 3465532. PMID 23000897.
- ^ Page Module:Citation/CS1/styles.css has no content.Bárcena C, Quesada V, De Sandre-Giovannoli A, Puente DA, Fernández-Toral J, Sigaudy S, Baban A, Lévy N, Velasco G, López-Otín C (2014). "Exome sequencing identifies a novel mutation in PIK3R1 as the cause of SHORT syndrome". BMC Med. Genet. 15: 51. doi:10.1186/1471-2350-15-51. PMC 4022398. PMID 24886349.
- ^ Page Module:Citation/CS1/styles.css has no content.Kang Q, Cao Y, Zolkiewska A (2001). "Direct interaction between the cytoplasmic tail of ADAM 12 and the Src homology 3 domain of p85alpha activates phosphatidylinositol 3-kinase in C2C12 cells". J. Biol. Chem. 276 (27): 24466–72. doi:10.1074/jbc.M101162200. PMID 11313349.
- ^ Page Module:Citation/CS1/styles.css has no content.Li E, Stupack DG, Brown SL, Klemke R, Schlaepfer DD, Nemerow GR (2000). "Association of p130CAS with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry". J. Biol. Chem. 275 (19): 14729–35. doi:10.1074/jbc.275.19.14729. PMID 10799562.
- ^ Page Module:Citation/CS1/styles.css has no content.Lavagna-Sévenier C, Marchetto S, Birnbaum D, Rosnet O (1998). "The CBL-related protein CBLB participates in FLT3 and interleukin-7 receptor signal transduction in pro-B cells". J. Biol. Chem. 273 (24): 14962–7. doi:10.1074/jbc.273.24.14962. PMID 9614102.
- ^ Page Module:Citation/CS1/styles.css has no content.Elly C, Witte S, Zhang Z, Rosnet O, Lipkowitz S, Altman A, Liu YC (1999). "Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation". Oncogene. 18 (5): 1147–56. doi:10.1038/sj.onc.1202411. PMID 10022120.
- ^ Page Module:Citation/CS1/styles.css has no content.De Sepulveda P, Okkenhaug K, Rose JL, Hawley RG, Dubreuil P, Rottapel R (1999). "Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation". EMBO J. 18 (4): 904–15. doi:10.1093/emboj/18.4.904. PMC 1171183. PMID 10022833.
- ^ Page Module:Citation/CS1/styles.css has no content.van Dijk TB, van Den Akker E, Amelsvoort MP, Mano H, Löwenberg B, von Lindern M (2000). "Stem cell factor induces phosphatidylinositol 3'-kinase-dependent Lyn/Tec/Dok-1 complex formation in hematopoietic cells". Blood. 96 (10): 3406–13. doi:10.1182/blood.V96.10.3406. hdl:1765/9530. PMID 11071635.
- ^ Page Module:Citation/CS1/styles.css has no content.Serve H, Hsu YC, Besmer P (1994). "Tyrosine residue 719 of the c-kit receptor is essential for binding of the P85 subunit of phosphatidylinositol (PI) 3-kinase and for c-kit-associated PI 3-kinase activity in COS-1 cells". J. Biol. Chem. 269 (8): 6026–30. doi:10.1016/S0021-9258(17)37564-6. PMID 7509796.
- ^ Page Module:Citation/CS1/styles.css has no content.Pagès F, Ragueneau M, Klasen S, Battifora M, Couez D, Sweet R, Truneh A, Ward SG, Olive D (1996). "Two distinct intracytoplasmic regions of the T-cell adhesion molecule CD28 participate in phosphatidylinositol 3-kinase association". J. Biol. Chem. 271 (16): 9403–9. doi:10.1074/jbc.271.16.9403. PMID 8621607.
- ^ Page Module:Citation/CS1/styles.css has no content.Lee DM, Patel DD, Pendergast AM, Haynes BF (1996). "Functional association of CD7 with phosphatidylinositol 3-kinase: interaction via a YEDM motif". Int. Immunol. 8 (8): 1195–203. doi:10.1093/intimm/8.8.1195. PMID 8918688.
- ^ Page Module:Citation/CS1/styles.css has no content.Subrahmanyam G, Rudd CE, Schneider H (2003). "Association of T cell antigen CD7 with type II phosphatidylinositol-4 kinase, a key component in pathways of inositol phosphate turnover". Eur. J. Immunol. 33 (1): 46–52. doi:10.1002/immu.200390006. PMID 12594831. S2CID 26388891.
- ^ Page Module:Citation/CS1/styles.css has no content.Ye K, Hurt KJ, Wu FY, Fang M, Luo HR, Hong JJ, Blackshaw S, Ferris CD, Snyder SH (2000). "Pike. A nuclear gtpase that enhances PI3kinase activity and is regulated by protein 4.1N". Cell. 103 (6): 919–30. doi:10.1016/S0092-8674(00)00195-1. PMID 11136977. S2CID 16610638.
- ^ Page Module:Citation/CS1/styles.css has no content.Gesbert F, Garbay C, Bertoglio J (1998). "Interleukin-2 stimulation induces tyrosine phosphorylation of p120-Cbl and CrkL and formation of multimolecular signaling complexes in T lymphocytes and natural killer cells". J. Biol. Chem. 273 (7): 3986–93. doi:10.1074/jbc.273.7.3986. PMID 9461587.
- ^ Page Module:Citation/CS1/styles.css has no content.Zhang S, Broxmeyer HE (1999). "p85 subunit of PI3 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells". Biochem. Biophys. Res. Commun. 254 (2): 440–5. doi:10.1006/bbrc.1998.9959. PMID 9918857.
- ^ Page Module:Citation/CS1/styles.css has no content.Dufour C, Guenou H, Kaabeche K, Bouvard D, Sanjay A, Marie PJ (2008). "FGFR2-Cbl interaction in lipid rafts triggers attenuation of PI3K/Akt signaling and osteoblast survival". Bone. 42 (6): 1032–9. doi:10.1016/j.bone.2008.02.009. PMID 18374639.
- ^ Page Module:Citation/CS1/styles.css has no content.Pandey A, Lazar DF, Saltiel AR, Dixit VM (1994). "Activation of the Eck receptor protein tyrosine kinase stimulates phosphatidylinositol 3-kinase activity". J. Biol. Chem. 269 (48): 30154–7. doi:10.1016/S0021-9258(18)43790-8. PMID 7982920.
- ^ a b Page Module:Citation/CS1/styles.css has no content.Shigematsu H, Iwasaki H, Otsuka T, Ohno Y, Arima F, Niho Y (1997). "Role of the vav proto-oncogene product (Vav) in erythropoietin-mediated cell proliferation and phosphatidylinositol 3-kinase activity". J. Biol. Chem. 272 (22): 14334–40. doi:10.1074/jbc.272.22.14334. PMID 9162069.
- ^ Page Module:Citation/CS1/styles.css has no content.Damen JE, Cutler RL, Jiao H, Yi T, Krystal G (1995). "Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity". J. Biol. Chem. 270 (40): 23402–8. doi:10.1074/jbc.270.40.23402. PMID 7559499.
- ^ Page Module:Citation/CS1/styles.css has no content.Hellyer NJ, Kim MS, Koland JG (2001). "Heregulin-dependent activation of phosphoinositide 3-kinase and Akt via the ErbB2/ErbB3 co-receptor". J. Biol. Chem. 276 (45): 42153–61. doi:10.1074/jbc.M102079200. PMID 11546794.
- ^ Page Module:Citation/CS1/styles.css has no content.Lin J, Adam RM, Santiestevan E, Freeman MR (1999). "The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells". Cancer Res. 59 (12): 2891–7. PMID 10383151.
- ^ Page Module:Citation/CS1/styles.css has no content.Gautreau A, Poullet P, Louvard D, Arpin M (1999). "Ezrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathway". Proc. Natl. Acad. Sci. U.S.A. 96 (13): 7300–5. Bibcode:1999PNAS...96.7300G. doi:10.1073/pnas.96.13.7300. PMC 22080. PMID 10377409.
- ^ Page Module:Citation/CS1/styles.css has no content.Chacko GW, Brandt JT, Coggeshall KM, Anderson CL (1996). "Phosphoinositide 3-kinase and p72syk noncovalently associate with the low affinity Fc gamma receptor on human platelets through an immunoreceptor tyrosine-based activation motif. Reconstitution with synthetic phosphopeptides". J. Biol. Chem. 271 (18): 10775–81. doi:10.1074/jbc.271.18.10775. PMID 8631888.
- ^ Page Module:Citation/CS1/styles.css has no content.Ibarrola I, Vossebeld PJ, Homburg CH, Thelen M, Roos D, Verhoeven AJ (1997). "Influence of tyrosine phosphorylation on protein interaction with FcgammaRIIa". Biochim. Biophys. Acta. 1357 (3): 348–58. doi:10.1016/S0167-4889(97)00034-7. PMID 9268059.
- ^ a b Page Module:Citation/CS1/styles.css has no content.Bertagnolo V, Marchisio M, Volinia S, Caramelli E, Capitani S (1998). "Nuclear association of tyrosine-phosphorylated Vav to phospholipase C-gamma1 and phosphoinositide 3-kinase during granulocytic differentiation of HL-60 cells". FEBS Lett. 441 (3): 480–4. doi:10.1016/S0014-5793(98)01593-2. PMID 9891995. S2CID 38371954.
- ^ Page Module:Citation/CS1/styles.css has no content.Holgado-Madruga M, Emlet DR, Moscatello DK, Godwin AK, Wong AJ (1996). "A Grb2-associated docking protein in EGF- and insulin-receptor signalling". Nature. 379 (6565): 560–4. Bibcode:1996Natur.379..560H. doi:10.1038/379560a0. PMID 8596638. S2CID 4271970.
- ^ Page Module:Citation/CS1/styles.css has no content.Rocchi S, Tartare-Deckert S, Murdaca J, Holgado-Madruga M, Wong AJ, Van Obberghen E (1998). "Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules". Mol. Endocrinol. 12 (7): 914–23. doi:10.1210/mend.12.7.0141. PMID 9658397.
- ^ Page Module:Citation/CS1/styles.css has no content.Lynch DK, Daly RJ (2002). "PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2". EMBO J. 21 (1–2): 72–82. doi:10.1093/emboj/21.1.72. PMC 125816. PMID 11782427.
- ^ Page Module:Citation/CS1/styles.css has no content.Crouin C, Arnaud M, Gesbert F, Camonis J, Bertoglio J (2001). "A yeast two-hybrid study of human p97/Gab2 interactions with its SH2 domain-containing binding partners". FEBS Lett. 495 (3): 148–53. doi:10.1016/S0014-5793(01)02373-0. PMID 11334882. S2CID 24499468.
- ^ Page Module:Citation/CS1/styles.css has no content.Saleem A, Kharbanda S, Yuan ZM, Kufe D (1995). "Monocyte colony-stimulating factor stimulates binding of phosphatidylinositol 3-kinase to Grb2.Sos complexes in human monocytes". J. Biol. Chem. 270 (18): 10380–3. doi:10.1074/jbc.270.18.10380. PMID 7737969.
- ^ Page Module:Citation/CS1/styles.css has no content.Wang J, Auger KR, Jarvis L, Shi Y, Roberts TM (1995). "Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase". J. Biol. Chem. 270 (21): 12774–80. doi:10.1074/jbc.270.21.12774. PMID 7759531.
- ^ Page Module:Citation/CS1/styles.css has no content.Hanna AN, Chan EY, Xu J, Stone JC, Brindley DN (1999). "A novel pathway for tumor necrosis factor-alpha and ceramide signaling involving sequential activation of tyrosine kinase, p21(ras), and phosphatidylinositol 3-kinase". J. Biol. Chem. 274 (18): 12722–9. doi:10.1074/jbc.274.18.12722. PMID 10212255.
- ^ Page Module:Citation/CS1/styles.css has no content.Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A, Downward J (1997). "Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras". Cell. 89 (3): 457–67. doi:10.1016/S0092-8674(00)80226-3. PMID 9150145. S2CID 14459536.
- ^ a b Page Module:Citation/CS1/styles.css has no content.Hamer I, Foti M, Emkey R, Cordier-Bussat M, Philippe J, De Meyts P, Maeder C, Kahn CR, Carpentier JL (2002). "An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events". Diabetologia. 45 (5): 657–67. doi:10.1007/s00125-002-0798-5. PMID 12107746.
- ^ Page Module:Citation/CS1/styles.css has no content.Hadari YR, Tzahar E, Nadiv O, Rothenberg P, Roberts CT, LeRoith D, Yarden Y, Zick Y (1992). "Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3'-kinase upon its association with pp185 (IRS-1) in intact rat livers". J. Biol. Chem. 267 (25): 17483–6. doi:10.1016/S0021-9258(19)37065-6. PMID 1381348.
- ^ Page Module:Citation/CS1/styles.css has no content.Morrison KB, Tognon CE, Garnett MJ, Deal C, Sorensen PH (2002). "ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation". Oncogene. 21 (37): 5684–95. doi:10.1038/sj.onc.1205669. PMID 12173038.
- ^ Page Module:Citation/CS1/styles.css has no content.Gual P, Gonzalez T, Grémeaux T, Barres R, Le Marchand-Brustel Y, Tanti JF (2003). "Hyperosmotic stress inhibits insulin receptor substrate-1 function by distinct mechanisms in 3T3-L1 adipocytes". J. Biol. Chem. 278 (29): 26550–7. doi:10.1074/jbc.M212273200. PMID 12730242.
- ^ Page Module:Citation/CS1/styles.css has no content.Argetsinger LS, Norstedt G, Billestrup N, White MF, Carter-Su C (1996). "Growth hormone, interferon-gamma, and leukemia inhibitory factor utilize insulin receptor substrate-2 in intracellular signaling". J. Biol. Chem. 271 (46): 29415–21. doi:10.1074/jbc.271.46.29415. PMID 8910607.
- ^ Page Module:Citation/CS1/styles.css has no content.Verdier F, Chrétien S, Billat C, Gisselbrecht S, Lacombe C, Mayeux P (1997). "Erythropoietin induces the tyrosine phosphorylation of insulin receptor substrate-2. An alternate pathway for erythropoietin-induced phosphatidylinositol 3-kinase activation". J. Biol. Chem. 272 (42): 26173–8. doi:10.1074/jbc.272.42.26173. PMID 9334184.
- ^ Page Module:Citation/CS1/styles.css has no content.Kim B, Cheng HL, Margolis B, Feldman EL (1998). "Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling". J. Biol. Chem. 273 (51): 34543–50. doi:10.1074/jbc.273.51.34543. PMID 9852124.
- ^ Page Module:Citation/CS1/styles.css has no content.Reddy SA, Huang JH, Liao WS (1997). "Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation". J. Biol. Chem. 272 (46): 29167–73. doi:10.1074/jbc.272.46.29167. PMID 9360994.
- ^ Page Module:Citation/CS1/styles.css has no content.Fuhrer DK, Yang YC (1996). "Complex formation of JAK2 with PP2A, P13K, and Yes in response to the hematopoietic cytokine interleukin-11". Biochem. Biophys. Res. Commun. 224 (2): 289–96. doi:10.1006/bbrc.1996.1023. PMID 8702385.
- ^ Page Module:Citation/CS1/styles.css has no content.Sánchez-Margalet V, Najib S (2001). "Sam68 is a docking protein linking GAP and PI3K in insulin receptor signaling". Mol. Cell. Endocrinol. 183 (1–2): 113–21. doi:10.1016/S0303-7207(01)00587-1. PMID 11604231. S2CID 24594450.
- ^ Page Module:Citation/CS1/styles.css has no content.Shen Z, Batzer A, Koehler JA, Polakis P, Schlessinger J, Lydon NB, Moran MF (1999). "Evidence for SH3 domain directed binding and phosphorylation of Sam68 by Src". Oncogene. 18 (33): 4647–53. doi:10.1038/sj.onc.1203079. PMID 10467411.
- ^ Page Module:Citation/CS1/styles.css has no content.Kozutsumi H, Toyoshima H, Hagiwara K, Yazaki Y, Hirai H (1994). "Human ltk receptor tyrosine kinase binds to PLC-gamma 1, PI3-K, GAP and Raf-1 in vivo". Oncogene. 9 (10): 2991–8. PMID 8084603.
- ^ Page Module:Citation/CS1/styles.css has no content.Ueno H, Honda H, Nakamoto T, Yamagata T, Sasaki K, Miyagawa K, Mitani K, Yazaki Y, Hirai H (1997). "The phosphatidylinositol 3' kinase pathway is required for the survival signal of leukocyte tyrosine kinase". Oncogene. 14 (25): 3067–72. doi:10.1038/sj.onc.1201153. PMID 9223670.
- ^ Page Module:Citation/CS1/styles.css has no content.Paz PE, Wang S, Clarke H, Lu X, Stokoe D, Abo A (2001). "Mapping the Zap-70 phosphorylation sites on LAT (linker for activation of T cells) required for recruitment and activation of signalling proteins in T cells". Biochem. J. 356 (Pt 2): 461–71. doi:10.1042/0264-6021:3560461. PMC 1221857. PMID 11368773.
- ^ Page Module:Citation/CS1/styles.css has no content.Shim EK, Moon CS, Lee GY, Ha YJ, Chae SK, Lee JR (2004). "Association of the Src homology 2 domain-containing leukocyte phosphoprotein of 76 kD (SLP-76) with the p85 subunit of phosphoinositide 3-kinase". FEBS Lett. 575 (1–3): 35–40. doi:10.1016/j.febslet.2004.07.090. PMID 15388330. S2CID 24678709.
- ^ Page Module:Citation/CS1/styles.css has no content.Vanhaesebroeck B, Welham MJ, Kotani K, Stein R, Warne PH, Zvelebil MJ, Higashi K, Volinia S, Downward J, Waterfield MD (1997). "P110delta, a novel phosphoinositide 3-kinase in leukocytes". Proc. Natl. Acad. Sci. U.S.A. 94 (9): 4330–5. Bibcode:1997PNAS...94.4330V. doi:10.1073/pnas.94.9.4330. PMC 20722. PMID 9113989.
- ^ Page Module:Citation/CS1/styles.css has no content.Guinebault C, Payrastre B, Racaud-Sultan C, Mazarguil H, Breton M, Mauco G, Plantavid M, Chap H (1995). "Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase". J. Cell Biol. 129 (3): 831–42. doi:10.1083/jcb.129.3.831. PMC 2120444. PMID 7537275.
- ^ Page Module:Citation/CS1/styles.css has no content.Karlsson T, Songyang Z, Landgren E, Lavergne C, Di Fiore PP, Anafi M, Pawson T, Cantley LC, Claesson-Welsh L, Welsh M (1995). "Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins". Oncogene. 10 (8): 1475–83. PMID 7537362.
- ^ Page Module:Citation/CS1/styles.css has no content.Kapeller R, Toker A, Cantley LC, Carpenter CL (1995). "Phosphoinositide 3-kinase binds constitutively to alpha/beta-tubulin and binds to gamma-tubulin in response to insulin". J. Biol. Chem. 270 (43): 25985–91. doi:10.1074/jbc.270.43.25985. PMID 7592789.
- ^ Page Module:Citation/CS1/styles.css has no content.Lan Z, Wu H, Li W, Wu S, Lu L, Xu M, Dai W (2000). "Transforming activity of receptor tyrosine kinase tyro3 is mediated, at least in part, by the PI3 kinase-signaling pathway". Blood. 95 (2): 633–8. doi:10.1182/blood.V95.2.633. PMID 10627473.
- ^ Page Module:Citation/CS1/styles.css has no content.Banin S, Truong O, Katz DR, Waterfield MD, Brickell PM, Gout I (1996). "Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases". Curr. Biol. 6 (8): 981–8. Bibcode:1996CBio....6..981B. doi:10.1016/S0960-9822(02)00642-5. PMID 8805332. S2CID 162267.
Further reading
Page Template:Refbegin/styles.css has no content.
- Page Module:Citation/CS1/styles.css has no content.Benito M, Valverde AM, Lorenzo M (1996). "IGF-I: a mitogen also involved in differentiation processes in mammalian cells". Int. J. Biochem. Cell Biol. 28 (5): 499–510. doi:10.1016/1357-2725(95)00168-9. PMID 8697095.
- Page Module:Citation/CS1/styles.css has no content.Snapper SB, Rosen FS (1999). "The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization". Annu. Rev. Immunol. 17: 905–29. doi:10.1146/annurev.immunol.17.1.905. PMID 10358777.
- Page Module:Citation/CS1/styles.css has no content.Katada T, Kurosu H, Okada T, Suzuki T, Tsujimoto N, Takasuga S, Kontani K, Hazeki O, Ui M (1999). "Synergistic activation of a family of phosphoinositide 3-kinase via G-protein coupled and tyrosine kinase-related receptors". Chem. Phys. Lipids. 98 (1–2): 79–86. doi:10.1016/S0009-3084(99)00020-1. PMID 10358930.
- Page Module:Citation/CS1/styles.css has no content.Zhang W, Samelson LE (2000). "The role of membrane-associated adaptors in T cell receptor signalling". Semin. Immunol. 12 (1): 35–41. doi:10.1006/smim.2000.0205. PMID 10723796.
- Page Module:Citation/CS1/styles.css has no content.Greenway AL, Holloway G, McPhee DA, Ellis P, Cornall A, Lidman M (2003). "HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication". J. Biosci. 28 (3): 323–35. doi:10.1007/BF02970151. PMID 12734410. S2CID 33749514.
- Page Module:Citation/CS1/styles.css has no content.Leavitt SA, SchOn A, Klein JC, Manjappara U, Chaiken IM, Freire E (2004). "Interactions of HIV-1 proteins gp120 and Nef with cellular partners define a novel allosteric paradigm". Curr. Protein Pept. Sci. 5 (1): 1–8. doi:10.2174/1389203043486955. PMID 14965316.
- Page Module:Citation/CS1/styles.css has no content.Joseph AM, Kumar M, Mitra D (2005). "Nef: "necessary and enforcing factor" in HIV infection". Curr. HIV Res. 3 (1): 87–94. doi:10.2174/1570162052773013. PMID 15638726.
Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found.
